We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GSTC market cap is 744.66k. The company's latest EPS is USD -0.0016 and P/E is 0.00.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -316k | -304k | -9.09M | -1.27M | -1.86M |
| Net Income | -2.28M | -542k | -9.8M | -1.49M | -1.95M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 142k | 90k | 6k | 10k | 0 |
| Total Liabilities | 827k | 749k | 732k | 1.21M | 1.43M |
| Total Equity | -685k | -659k | -726k | -1.2M | -1.43M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -261k | -240k | -751k | -327k | -205k |
| Investing | N/A | -2k | N/A | N/A | N/A |
| Financing | 269k | 223k | 676k | 327k | 199k |
| Market Cap | 744.66k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 1.24B |
| Average Volume (1 week) | 2.29M |
| Average Volume (1 Month) | 5.41M |
| 52 Week Change | -72.73% |
| 52 Week High | 0.0043 |
| 52 Week Low | 0.0003 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Globestar Therapeutics Corporation (PK) |
| Address |
30 n gould st sheridan, wyoming 82801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
